YC-1 enhances the anti-tumor activity of sorafenib through inhibition of signal transducer and activator of transcription 3 (STAT3) in hepatocellular carcinoma | |
Kong, Jian; Kong, Fandong; Gao, Jun; Zhang, Qiangbo; Dong, Shuying; Gu, Fang; Ke, Shan; Pan, Bing; Shen, Qiang; Sun, Huichuan | |
刊名 | MOLECULAR CANCER |
2014 | |
卷号 | 13 |
关键词 | YC-1 Sorafenib Hepatocellular carcinoma STAT3 |
ISSN号 | 1476-4598 |
URL标识 | 查看原文 |
语种 | 英语 |
内容类型 | 期刊论文 |
URI标识 | http://www.corc.org.cn/handle/1471x/4881008 |
专题 | 复旦大学上海医学院 |
推荐引用方式 GB/T 7714 | Kong, Jian,Kong, Fandong,Gao, Jun,et al. YC-1 enhances the anti-tumor activity of sorafenib through inhibition of signal transducer and activator of transcription 3 (STAT3) in hepatocellular carcinoma[J]. MOLECULAR CANCER,2014,13. |
APA | Kong, Jian.,Kong, Fandong.,Gao, Jun.,Zhang, Qiangbo.,Dong, Shuying.,...&Sun, Wenbing.(2014).YC-1 enhances the anti-tumor activity of sorafenib through inhibition of signal transducer and activator of transcription 3 (STAT3) in hepatocellular carcinoma.MOLECULAR CANCER,13. |
MLA | Kong, Jian,et al."YC-1 enhances the anti-tumor activity of sorafenib through inhibition of signal transducer and activator of transcription 3 (STAT3) in hepatocellular carcinoma".MOLECULAR CANCER 13(2014). |
个性服务 |
查看访问统计 |
相关权益政策 |
暂无数据 |
收藏/分享 |
除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。
修改评论